PR92369

MUMBAI, India, Oct. 15, 2021 /PRNewswire=KYODO JBN/ --

- UPL is the largest manufacturer and distributor of biosolutions worldwide,

fifth-largest agribusiness globally.

- Chr. Hansen is the owner of one of the world’s largest commercial collections

of bacteria, with more than 28,000 strains

- The biosolutions market set to grow to $10bn* USD by 2025 as consumers demand

more sustainable food systems

UPL Ltd. (‘UPL’) (NSE: UPL) (BSE: 512070), a world-leading champion of

sustainable agriculture and OpenAg(TM), has announced a long-term strategic

collaboration with Chr. Hansen, a global bioscience company, to develop

microbial-based biosolutions (including biostimulants and biopesticides) that

will help growers around the world fight pests and diseases, and improve crop

quality and yields.

Through this collaboration, UPL will use its global presence to undertake

research and identify opportunities and product concepts to address  farmers’

pain points. From these insights, Chr. Hansen will design biological products

based on their microbial capabilities and UPL will register and commercialize

these products via its extensive global distribution network.

UPL is the world’s largest manufacturer and distributor of biosolutions, and

earlier this year launched ‘NPP – Natural Plant Protection’ – a new global

business unit championing UPL’s comprehensive portfolio of natural and

biologically derived agricultural inputs and technologies.

Vicente Gongora, Chief Marketing Officer at UPL Ltd. said:

“Biosolutions are a core pillar of our global purpose and work to reimagine

sustainability – for food systems, for farmers, and for our environment.

Building on the launch of NPP earlier in the year, we are proud to partner with

Chr. Hansen to further expand our portfolio of products and technologies – and

to offer new and sustainable solutions for more farming communities.

“Consolidating our distribution networks and R&D facilities alongside Chr.

Hansen’s unique microbial experience and expertise presents a powerful

opportunity to change the game for farmers and for sustainable agriculture

globally. We look forward to sharing more news on the biological solutions that

we are developing for the future, and we are excited about the legacy we will

build together.”

Kim Christensen, Vice President of Plant Health at Chr. Hansen said:

“UPL is a significant distributor of biosolutions worldwide. Combining that

with Chr. Hansen’s significant innovations in research and development, as well

as our unique microbial capabilities and ability to breed our own bacteria,

will mean better, targeted products that can go to market faster. The

partnership is an important step in our 2025 strategy of growing a better world

naturally. In essence, the collaboration aims to establish a product pipeline

that has the best interests of farmers at heart.”

The UPL-Chr. Hansen partnership has already identified several projects

relevant to farmers globally and aims to develop a product pipeline for all

major crops that will enable farmers to fight crop diseases and increase their

yields. The companies are expecting the first registrations to start coming by

the end of 2022.

* Value for Biocontrol & BioStimulants Market

Source: UPL Ltd.